» Articles » PMID: 6133028

[Trials in Pressure Regulation with Metipranolol Eyedrops in Special Forms of Glaucoma in Ophthalmologic Practice]

Overview
Publisher Thieme
Specialty Ophthalmology
Date 1983 Feb 1
PMID 6133028
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

This paper presents the results of a study on the effect of Metipranolol eye drops (Betamann) in 10 patients. The drops were tested with the following forms of glaucoma: glaucoma associated with alpha-kia, neovascular glaucoma, exfoliative glaucoma, pigmentary glaucoma, juvenile glaucoma. Some patients required treatment in combination with miotics. Metipranolol eye drops reduced intraocular pressure by about 15 percent for a prolonged period of time. The pressure-lowering effect was maintained during an observation period of twelve months. Visual acuity and visual fields were constant. The drug was tolerated well subjectively by almost all the patients.

Citing Articles

Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.

Battershill P, Sorkin E Drugs. 1988; 36(5):601-15.

PMID: 2905641 DOI: 10.2165/00003495-198836050-00004.


A study on the ocular and extraocular pharmacology of metipranolol.

SUGRUE M, Armstrong J, Gautheron P, Mallorga P, Viader M Graefes Arch Clin Exp Ophthalmol. 1985; 222(3):123-7.

PMID: 2858433 DOI: 10.1007/BF02173535.